21. Are there any differences in the most frequently injected muscles in upper, lower and upper, and lower limbs, with regard to the treatment goal areas? An overview of the real-life clinical practice in a reference spasticity clinic. (25th December 2016) Authors: Castro, João Paulo; Pinto, Daniela; Gorayeb, Melissa; Falcão, Carolina; Jacinto, Jorge Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Assembly and disassembly of the SNARE complex. (25th December 2016) Authors: Brunger, Axel T. Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Assessment of botulinum toxin treatment in pediatric cerebral palsy patients in the United States' managed medicaid population. (25th December 2016) Authors: Sawhney, Tia Goss; Bains, Savreet; Pulgar, Sonia; Pyenson, Bruce; Ferro, Christine; Gooch, Judy; Noritz, Garey; Wright, Edward Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Augmentation of the catalytic activity of Botulinum neurotoxin type B does not result in increased potency in physiologic systems. (25th December 2016) Authors: Elliott, Mark; Farrow, Paul; Favre-Guilmard, Christine; Hornby, Fraser; Liu, Sai Man; Maignel-Ludop, Jacquie; Marlin, Sandra; Mir, Imran; Palan, Shilpa; Kalinichev, Mikhail; Beard, Matthew; Krupp, Johannes Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Author Index. (25th December 2016) Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: I Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Baseline characteristics of patients from a pilot study to assess the effect of early use of abobotulinumtoxinA (Dysport®) after stroke on spasticity progression. (25th December 2016) Authors: Rosales, Raymond L.; Goh, Khean Jin; Kumthornthip, Witsanu; Balcaitiene, Jovita; Maisonobe, Pascal; Kong, Keng He Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Beyond rhytids: Facial contouring with neurotoxins. (25th December 2016) Authors: Yoelin, Steve Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Biological toxins detection: A rapid diagnosis in an emergency response. (25th December 2016) Authors: Lopes de Carvalho, Isabel; Cordeiro, Rita; Saraiva, Margarida; Cunha, Isabel Campos; Pelerito, Ana; Núncio, Maria Sofia Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. BoNT injections for hyperhidrosis: Technical pearls. (25th December 2016) Authors: Glaser, Dee Anna Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Botulinum neurotoxin (BoNT) for pain syndromes. (25th December 2016) Authors: Jabbari, Bahman Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗